Concerning the molecular phenotypes in breast cancer patients, the SUVmax from 68Ga-NOTA-RGD-BBN (68Ga-BBN-RGD) PET was lower in ER(−) primary lesions than in ER(+) primary lesions (p <0.01). This evidence concerns the gene ESR1 and breast carcinoma.